These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 32258021)
1. BAP1 Immunoreactivity Correlates with Gene Expression Class in Uveal Melanoma. See TR; Stålhammar G; Phillips S; Grossniklaus HE Ocul Oncol Pathol; 2020 Mar; 6(2):129-137. PubMed ID: 32258021 [TBL] [Abstract][Full Text] [Related]
2. Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes. Decatur CL; Ong E; Garg N; Anbunathan H; Bowcock AM; Field MG; Harbour JW JAMA Ophthalmol; 2016 Jul; 134(7):728-33. PubMed ID: 27123562 [TBL] [Abstract][Full Text] [Related]
3. Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis. Szalai E; Wells JR; Ward L; Grossniklaus HE Ophthalmology; 2018 Feb; 125(2):203-209. PubMed ID: 28823399 [TBL] [Abstract][Full Text] [Related]
4. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma. Shah AA; Bourne TD; Murali R Pathology; 2013 Dec; 45(7):651-6. PubMed ID: 24247622 [TBL] [Abstract][Full Text] [Related]
5. BAP1 Immunostain Status in Intraocular Biopsy Specimens for Uveal Melanoma Highly Correlates with Other Prognostic Markers. Ida CM; Pulido J; Greipp PT; Garcia JJ; Olsen TW; Dalvin L; Salomão DR Ocul Oncol Pathol; 2022 Feb; 8(1):22-29. PubMed ID: 35356602 [TBL] [Abstract][Full Text] [Related]
6. Preferentially Expressed Antigen in Melanoma Immunohistochemistry Labeling in Uveal Melanomas. Ahmadian SS; Dryden IJ; Naranjo A; Toland A; Cayrol RA; Born DE; Egbert PS; Brown RA; Mruthyunjaya P; Lin JH Ocul Oncol Pathol; 2022 Jun; 8(2):133-140. PubMed ID: 35959159 [TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma. Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of BAP1 and Preferentially Expressed Antigen in Melanoma (PRAME) Immunohistochemistry in Uveal Melanomas. Han LM; Lee KW; Uludag G; Seider MI; Afshar AR; Bloomer MM; Pekmezci M Mod Pathol; 2023 Apr; 36(4):100081. PubMed ID: 36788079 [TBL] [Abstract][Full Text] [Related]
9. BRCA-associated protein1 (BAP1) immunohistochemical stain reliability in postbrachytherapy uveal melanoma enucleation specimens. Eiger-Moscovich M; Shields CL; Eagle RC; Milman T Indian J Ophthalmol; 2024 May; 72(Suppl 3):S459-S467. PubMed ID: 38324631 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Factor Utility of BAP1 Immunohistochemistry in Uveal Melanoma: A Single Center Study in Spain. Tabuenca Del Barrio L; Nova-Camacho LM; Zubicoa Enériz A; Martínez de Espronceda Ezquerro I; Córdoba Iturriagagoitia A; Borque Rodríguez-Maimón E; García-Layana A Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771510 [TBL] [Abstract][Full Text] [Related]
11. Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma. Farquhar N; Thornton S; Coupland SE; Coulson JM; Sacco JJ; Krishna Y; Heimann H; Taktak A; Cebulla CM; Abdel-Rahman MH; Kalirai H J Pathol Clin Res; 2018 Jan; 4(1):26-38. PubMed ID: 29416875 [TBL] [Abstract][Full Text] [Related]
12. Prognostic parameters in uveal melanoma and their association with BAP1 expression. van Essen TH; van Pelt SI; Versluis M; Bronkhorst IH; van Duinen SG; Marinkovic M; Kroes WG; Ruivenkamp CA; Shukla S; de Klein A; Kiliç E; Harbour JW; Luyten GP; van der Velden PA; Verdijk RM; Jager MJ Br J Ophthalmol; 2014 Dec; 98(12):1738-43. PubMed ID: 25147369 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma. Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up. Yue H; Qian J; Yuan Y; Zhang R; Bi Y; Meng F; Xuan Y Curr Eye Res; 2017 May; 42(5):759-765. PubMed ID: 27911584 [TBL] [Abstract][Full Text] [Related]
15. Tumour Angiogenesis in Uveal Melanoma Is Related to Genetic Evolution. Brouwer NJ; Gezgin G; Wierenga APA; Bronkhorst IHG; Marinkovic M; Luyten GPM; Versluis M; Kroes WGM; van der Velden PA; Verdijk RM; Jager MJ Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31337000 [TBL] [Abstract][Full Text] [Related]
17. BAP1 germline mutation in two first grade family members with uveal melanoma. Maerker DA; Zeschnigk M; Nelles J; Lohmann DR; Worm K; Bosserhoff AK; Krupar R; Jägle H Br J Ophthalmol; 2014 Feb; 98(2):224-7. PubMed ID: 24187051 [TBL] [Abstract][Full Text] [Related]
18. Altered Nuclear Expression of the Deubiquitylase BAP1 Cannot be Used as a Prognostic Marker for Canine Melanoma. Jama N; Farquhar N; Butt Z; Coupland SE; Sacco JJ; Scase T; Fielding AB; Coulson JM; Kalirai H; Killick DR J Comp Pathol; 2018 Jul; 162():50-58. PubMed ID: 30060843 [TBL] [Abstract][Full Text] [Related]